793 related articles for article (PubMed ID: 30082668)
21. Transcriptional regulation of
Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X
J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904
[TBL] [Abstract][Full Text] [Related]
22. O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.
Nagel AK; Ball LE
Amino Acids; 2014 Oct; 46(10):2305-16. PubMed ID: 25173736
[TBL] [Abstract][Full Text] [Related]
23. Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation.
Gorelik A; Bartual SG; Borodkin VS; Varghese J; Ferenbach AT; van Aalten DMF
Nat Struct Mol Biol; 2019 Nov; 26(11):1071-1077. PubMed ID: 31695185
[TBL] [Abstract][Full Text] [Related]
24. O-Linked N-Acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Interact with Mi2β Protein at the Aγ-Globin Promoter.
Zhang Z; Costa FC; Tan EP; Bushue N; DiTacchio L; Costello CE; McComb ME; Whelan SA; Peterson KR; Slawson C
J Biol Chem; 2016 Jul; 291(30):15628-40. PubMed ID: 27231347
[TBL] [Abstract][Full Text] [Related]
25. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
26. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
27. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
[TBL] [Abstract][Full Text] [Related]
28. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.
Butkinaree C; Park K; Hart GW
Biochim Biophys Acta; 2010 Feb; 1800(2):96-106. PubMed ID: 19647786
[TBL] [Abstract][Full Text] [Related]
29. O-GlcNAcylation and its role in the immune system.
Chang YH; Weng CL; Lin KI
J Biomed Sci; 2020 Apr; 27(1):57. PubMed ID: 32349769
[TBL] [Abstract][Full Text] [Related]
30. Demystifying O-GlcNAcylation: hints from peptide substrates.
Shi J; Ruijtenbeek R; Pieters RJ
Glycobiology; 2018 Nov; 28(11):814-824. PubMed ID: 29635275
[TBL] [Abstract][Full Text] [Related]
31. Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex.
Lu P; Liu Y; He M; Cao T; Yang M; Qi S; Yu H; Gao H
Nat Commun; 2023 Oct; 14(1):6952. PubMed ID: 37907462
[TBL] [Abstract][Full Text] [Related]
32. The potential role of O-GlcNAc modification in cancer epigenetics.
Forma E; Jóźwiak P; Bryś M; Krześlak A
Cell Mol Biol Lett; 2014 Sep; 19(3):438-60. PubMed ID: 25141978
[TBL] [Abstract][Full Text] [Related]
33. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
[TBL] [Abstract][Full Text] [Related]
34.
Liu L; Li L; Ma C; Shi Y; Liu C; Xiao Z; Zhang Y; Tian F; Gao Y; Zhang J; Ying W; Wang PG; Zhang L
J Biol Chem; 2019 Nov; 294(45):16620-16633. PubMed ID: 31527085
[No Abstract] [Full Text] [Related]
35. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
36. O-GlcNAcylation, a sweet link to the pathology of diseases.
Nie H; Yi W
J Zhejiang Univ Sci B; 2019 May; 20(5):437-448. PubMed ID: 31090269
[TBL] [Abstract][Full Text] [Related]
37. The Sulfur-Linked Analogue of O-GlcNAc (S-GlcNAc) Is an Enzymatically Stable and Reasonable Structural Surrogate for O-GlcNAc at the Peptide and Protein Levels.
De Leon CA; Levine PM; Craven TW; Pratt MR
Biochemistry; 2017 Jul; 56(27):3507-3517. PubMed ID: 28627871
[TBL] [Abstract][Full Text] [Related]
38. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.
Ogawa M; Sawaguchi S; Kamemura K; Okajima T
Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182
[TBL] [Abstract][Full Text] [Related]
39. Sustained
Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
[TBL] [Abstract][Full Text] [Related]
40. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]